• How IL-7 Drives Glucocorticoid Resistance in T-ALL

  2026-09-22

  Meyer and colleagues show that glucocorticoids can paradoxically promote resistance in a subset of T cell acute lymphoblastic leukemias by increasing IL-7 receptor signaling and BCL-2 expression. The study connects a normal thymocyte survival mechanism to leukemia treatment response and identifies the IL-7R/JAK/STAT5/BCL-2 axis as a potentially reversible source of steroid resistance.

• Dasatinib: A Causal Perturbation Guide

  2026-09-22

  Dasatinib (BMS-354825) can do more than suppress kinase activity: it can help separate target engagement, adhesion signaling, tumor-cell state, and metastatic behavior. This guide connects validated Src/Bcr-Abl pharmacology with the SNAI1–PIK3R2/p-EphA2 findings in thymic epithelial tumors while clearly defining the evidence boundaries.

• GI 254023X: ADAM10 Inhibitor Workflow Guide

  2026-09-21

  GI 254023X combines nanomolar ADAM10 inhibition with more than 100-fold selectivity over ADAM17, making it useful for separating sheddase-dependent signaling from nonspecific metalloprotease effects. This guide translates that profile into practical Jurkat, endothelial-barrier, and mouse-model workflows with assay-matched controls and troubleshooting steps.

• Calpeptin: Assay Logic for Fibrosis Research

  2026-09-21

  Calpeptin is a potent calpain inhibitor for investigating how calcium-dependent proteolysis intersects with cell death, inflammation, and pulmonary fibrosis. This article provides an assay-centered framework for separating mechanism, phenotype, and translational interpretation.

• TMRE Assays: Linking ΔΨm to Cell Fate

  2026-09-20

  A mechanism-focused guide to using TMRE fluorescence to connect sodium-driven mitochondrial dysfunction with apoptosis, necrosis, and translational decision-making. The article explains how the TMRE mitochondrial Membrane Potential Assay Kit supports controlled, scalable mitochondrial function analysis while clarifying the limits of ΔΨm as a standalone endpoint.

• NVP-BGJ398 Phosphate: Readouts That Matter

  2026-09-19

  NVP-BGJ398 phosphate is a selective FGFR1–3 inhibitor whose value extends beyond simple viability assays. This article presents a pathway-to-phenotype framework for interpreting FGFR signaling in cancer and SLC26A2-related skeletal models.

• Inflammation in Ischemic Stroke: Biomarkers to Treatment

  2026-09-18

  This 2025 Frontiers in Immunology review organizes the fragmented evidence linking ischemia, neuroinflammation, blood–brain barrier disruption, peripheral immune activation, biomarkers, and treatment. Its main contribution is a phase-aware, clinically oriented framework that connects inflammatory mechanisms with diagnosis, prognosis, and therapeutic development while highlighting both conventional and traditional Chinese medicine approaches.

• Live-Dead Cell Staining Kit for Biomaterial Studies

  2026-09-18

  Learn how the Live-Dead Cell Staining Kit distinguishes membrane integrity from metabolic status in advanced biomaterial experiments. This guide applies Calcein-AM Propidium Iodide staining to hemostatic adhesive research, microscopy, flow cytometry, and assay-quality decisions.

• Quizartinib (AC220) in FLT3 AML Workflows

  2026-09-17

  Build more interpretable AML experiments with Quizartinib (AC220), from rapid FLT3 target engagement assays to genotype-aware resistance studies and xenograft validation. This guide emphasizes dose design, orthogonal readouts, and troubleshooting so low-nanomolar activity is not confused with nonspecific cytotoxicity.

• ATRX-Deficient Glioma: RTK/PDGFR Inhibitor Sensitivity

  2026-09-17

  The reference study identifies ATRX deficiency as a potential determinant of sensitivity to multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination experiments further indicate that RTK inhibition with Temozolomide may produce enhanced toxicity in ATRX-deficient models, supporting ATRX-aware interpretation of therapeutic studies.

• β-Elemene Inhibits Adipogenesis Through AMPK

  2026-09-16

  The reference study shows that β-Elemene suppresses MDI-induced adipogenesis in 3T3-L1 cells, reduces lipid accumulation, and improves glucose consumption in an insulin-resistance model. Its main contribution is linking these metabolic effects to restoration of AMPK pathway activity, providing a useful in vitro framework for studying β-Elemene and obesity-related cellular dysfunction.

• Sodium Overload, Mitochondrial Failure, and NECSO

  2026-09-16

  Qiao and colleagues identify mitochondrial energy failure as the central execution mechanism in sodium-overload-executed necrosis (NECSO). Their findings connect TRPM4-dependent Na+ entry to mitochondrial Na+ accumulation, NCLX-mediated Ca2+ loss, impaired oxidative metabolism, ATP depletion, and eventual failure of ion homeostasis.

• AEBSF.HCl: A Strategic Lens on Protease Biology

  2026-09-15

  AEBSF.HCl offers translational researchers a way to interrogate serine-protease contributions across necroptosis, amyloid precursor protein processing, and cell-lysis models—while preserving a critical distinction between serine-protease activity and cathepsin-driven mechanisms.

• Coelenterazine for ROS Reporter Assays

  2026-09-15

  Coelenterazine links luciferase-compatible reporting with direct chemiluminescent detection of superoxide and peroxynitrite. This guide shows how to adapt it for AVP secretion studies, oxidative stress measurement, BRET, high-throughput screening, and cancer-associated reactive oxygen species imaging while controlling solvent, timing, and signal-specificity confounders.

• CCR5 Extracellular Vesicles in Rheumatoid Arthritis

  2026-09-14

  A 2025 study identifies CCR5-bearing extracellular vesicles from rheumatoid arthritis synovial fibroblasts as active mediators of chondrocyte inflammation, cartilage destruction, and bone erosion. Using CCR5-deficient vesicles and vesicle-encapsulated Maraviroc in vitro and in an adjuvant-induced arthritis model, the work connects extracellular-vesicle trafficking with NF-κB-dependent joint pathology.

8017 records 1/535 page Next 12345 下5页 Last page